Derek DiRocco - 16 May 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Reporting relationship: Director
Issuer ticker: ETNB
Reported as of: 16 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2022, 16:09:41 UTC
Prior SEC filing: 21 Jun 2021
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Ryan A. Murr, as attorney-in-fact for Derek DiRocco

Key filing fact

Derek DiRocco filed Form 4 for 89bio, Inc. (ETNB) on 18 May 2022.

Key facts

This page summarizes Derek DiRocco's Form 4 filing for 89bio, Inc. (ETNB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 May 2022, 16:09.

Change

Previous filing in this sequence was filed on 21 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ETNB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 16 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $2.64
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in full on May 16, 2023, subject to the Reporting Person's continued service to the Issuer through such date.